Everest Medicines Limited 雲頂新耀有限公司
Main board
| Name | ⚥ | Age in 2024 |
Position | From | Until | |
|---|---|---|---|---|---|---|
| 1 | Blanchard, Kerry Levan | M | 68 | CEOChief Executive Officer | 2020-02 | 2022-08-26 |
| 2 | Cho, William Ki Chul 曹基哲 | M | 47 | NEDNon-Executive Director | 2024-01-12 | |
| 3 | Chui, Hoi Yam 徐海音 | F | 57 | INEDIndependent Non-Executive Director | 2023-01-19 | |
| 4 | Feng, Honggang 馮洪剛 | M | 60 | NEDNon-Executive Director | 2024-02-09 | |
| 5 | Fu, Wei (1982) 傅唯 | M | 42 | ChChairman | 2017-07 | |
| 6 | Gong, Yubo 龔聿波 | M | 39 | NEDNon-Executive Director | 2020-06 | 2024-02-09 |
| 7 | Jiang, Shidong (1968) 蔣世東 | M | 56 | INEDIndependent Non-Executive Director | 2020-09-25 | |
| 8 | Kang, Lan 康嵐 | F | 56 | NEDNon-Executive Director | 2020-12-22 | 2024-01-12 |
| 9 | Li, Yifan (1967) 李軼梵 | M | 57 | INEDIndependent Non-Executive Director | 2020-09-25 | |
| 10 | Luo, Yongqing (1969) 羅永慶 | M | 55 | CEOChief Executive Officer | 2022-09-19 | |
| 11 | Tan, Bo (1973) 譚擘 | M | 51 | INEDIndependent Non-Executive Director | 2020-09-25 | 2023-01-19 |
| 12 | Woo, Ian Ying 何穎 | M | 52 | Pres, FDPresident, Finance Director | 2018-12 | |
| 13 | Zhang, Xiaofan (SFC:ANY097) 張曉帆 | M | 40 | ED, COOExecutive Director, Chief Operating Officer | 2017-11 | 2023-03-31 |
Manager/adviser/other
| Name | ⚥ | Age in 2024 |
Position | From | Until | |
|---|---|---|---|---|---|---|
| 1 | Lau, Yee Wa 劉綺華 | F | 51 | CoSecCompany Secretary | ||
| 2 | Liu, Leah 劉栩昕 | F | 40 | CoSecCompany Secretary | 2022-03-28 | |
| 3 | Yin, Yin (1972) 印茵 | F | 52 | CoSecCompany Secretary | 2022-01-31 |
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy